SURG (SurgePays, Inc. Common Stock) Stock Analysis - AI Report

SurgePays, Inc. Common Stock (SURG) is a publicly traded Technology sector company. As of May 21, 2026, SURG trades at $0.50 with a market cap of $13.28M and a P/E ratio of -0.28. SURG moved -5.29% today. Year to date, SURG is -70.58%; over the trailing twelve months it is -84.27%. Its 52-week range spans $0.46 to $3.47. Analyst consensus is buy with an average price target of $5.00. Rallies surfaces SURG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on SURG?

Rallies AI research for SURG combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

SURG Key Metrics

Key financial metrics for SURG
MetricValue
Price$0.50
Market Cap$13.28M
P/E Ratio-0.28
EPS$-1.80
Dividend Yield0.00%
52-Week High$3.47
52-Week Low$0.46
Volume0
Avg Volume0
Revenue (TTM)$56.96M
Net Income$-36.07M
Gross Margin-18.59%

Latest SURG News

Recent SURG Insider Trades

  • May David Allen bought 28.42K (~$45.45K) on Dec 10, 2025.
  • May David Allen bought 10.00K (~$16.20K) on Dec 10, 2025.
  • May David Allen sold 63.00K (~$177.28K) on Jun 6, 2025.

SURG Analyst Consensus

2 analysts cover SURG: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.00.

Common questions about SURG

What is the AI research view on SURG?
Rallies AI research for SURG combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for SURG?
Rallies AI research for SURG combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is SURG research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SURG. It does not provide personalized investment advice.
SURG

SURG